Table 3.
Response after Second Chemoembolization according to EASL for the 50 Patients Who Did Not Respond to First Chemoembolization
Note.—Data are numbers of patients.
Patients who responded to second chemoembolization (22 patients, 44%). For example, the third row describes the response to the second chemoembolization for the 39 patients in the EASL IV group. Of those patients, 23 remained stable at EASL IV after the second chemoembolization, five showed EASL III response, four showed EASL II response, and seven showed EASL I response. No patients progressed during the follow-up period (median, 220 weeks).